Related Experiment Video
Updated: Feb 17, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
The Search for 'Evolution-Proof' Antibiotics
1Biology Department, McGill University, Avenue Docteur Penfield, Montreal, Quebec H3A 1B1, Canada; Zoology Department, Oxford University, South Parks Road, Oxford OX1 3PS, UK.
Abstract:
The effectiveness of antibiotics has been widely compromised by the evolution of resistance among pathogenic bacteria. It would be restored by the development of antibiotics to which bacteria cannot evolve resistance. We first discuss two kinds of 'evolution-proof' antibiotic. The first comprises literally evolution-proof antibiotics to which bacteria cannot become resistant by mutation or horizontal gene transfer. The second category comprises agents to which resistance may arise, but so rarely that it does not become epidemic. The likelihood that resistance to a novel agent will spread is evaluated here by a simple model that includes biological and therapeutic parameters governing the evolution of resistance within hosts and the transmission of resistant strains between hosts. This model leads to the conclusion that epidemic spread is unlikely if the frequency of mutations that confer resistance falls below a defined minimum value, and it identifies potential targets for intervention to prevent the evolution of resistance. Whether or not evolution-proof antibiotics are ever found, searching for them is likely to improve the deployment of new and existing agents by advancing our understanding of how resistance evolves.
Insights
Developing
Area of Science:
- Microbiology
- Evolutionary Biology
- Pharmacology
Background:
- Antibiotic resistance in pathogenic bacteria is a major global health threat, diminishing the effectiveness of existing treatments.
- The emergence of bacteria resistant to antibiotics necessitates the development of novel therapeutic strategies.
- Understanding the evolutionary dynamics of antibiotic resistance is crucial for effective intervention.
Purpose of the Study:
- To explore the concept of 'evolution-proof' antibiotics that could restore therapeutic efficacy.
- To model the likelihood of resistance spread for novel antibiotic agents.
- To identify targets for interventions aimed at preventing antibiotic resistance evolution.
Main Methods:
- Discussion of two categories of 'evolution-proof' antibiotics: those resistant to mutation/gene transfer and those with very rare resistance emergence.
- Development of a simple mathematical model to evaluate resistance spread.
- Inclusion of biological and therapeutic parameters in the model, covering within-host resistance evolution and between-host transmission.
Main Results:
- The model suggests epidemic spread of resistance is unlikely if the mutation frequency conferring resistance falls below a critical threshold.
- Identified specific targets for interventions to mitigate the evolution of antibiotic resistance.
- The search for 'evolution-proof' antibiotics can enhance the deployment of current and future antimicrobial agents.
Conclusions:
- The development of antibiotics that prevent or significantly slow resistance evolution is a critical goal.
- A predictive model aids in understanding the conditions under which antibiotic resistance may or may not become epidemic.
- Continued research into novel antibiotics and resistance mechanisms will improve antimicrobial stewardship and treatment strategies.
More Related Videos
Related Concept Videos
The Evidence for Evolution
Antibiotic Selection
Transduction
Development of Antibiotic Resistance
Genome Size and the Evolution of New Genes
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

